ribosomal protein SA pseudogene 1Genealiases: LAMR1P · LAMR1P1 · RPSA_24_1712 · dJ1193N1.1
Q-omics provides the consensus-scored RPSAP1 profile across patient tissues and cancer cell-line models. RPSAP1 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in STAD. Among the 18 cancer types available for tumor–normal comparison, RPSAP1 is differentially expressed in 7, with the highest sampling consensus in BRCA. Additionally, RPSAP1 RNA expression shows 6,583 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight STAD, and BRCA as cancer lineages where RPSAP1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPSAP1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPSAP1 survival associations across molecular data types. RPSAP1 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPSAP1 RNA expression–survival associations across cancer types. High RPSAP1 expression shows unfavorable associations in STAD, ACC, MESO, LIHC, BRCA and CHOL. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .010). Together, the overview and detailed table identify STAD as the clearest survival context for RPSAP1 RNA expression.
This table summarizes RPSAP1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for RPSAP1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPSAP1 shows lower tumor expression in ESCA and higher tumor expression in BRCA, THCA, KIRP, PRAD and UCEC. The BRCA box plot shows higher RPSAP1 RNA expression in tumor versus normal tissue (log2 FC = +0.048, t-test p = .004).
This table shows molecular features associated with RPSAP1 in patient tissues and cancer cell lines. In patient samples, RPSAP1 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
